These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1680625)
1. The disposition and metabolism of [14C]piritrexim in rats after intravenous and oral administration. Woolley JL; Deangelis DV; Crouch RC; Shockcor JP; Sigel CW Drug Metab Dispos; 1991; 19(3):600-8. PubMed ID: 1680625 [TBL] [Abstract][Full Text] [Related]
2. The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration. Woolley JL; Deangelis DV; Grace ME; Liao SH; Crouch RC; Sigel CW Drug Metab Dispos; 1991; 19(6):1139-46. PubMed ID: 1687022 [TBL] [Abstract][Full Text] [Related]
3. Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase. Sigel CW; Macklin AW; Woolley JL; Johnson NW; Collier MA; Blum MR; Clendeninn NJ; Everitt BJ; Grebe G; Mackars A NCI Monogr; 1987; (5):111-20. PubMed ID: 3431588 [TBL] [Abstract][Full Text] [Related]
4. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog. Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice. Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094 [TBL] [Abstract][Full Text] [Related]
6. Disposition of [14C]avitriptan in rats and humans. Marathe PH; Greene DS; Barbhaiya RH Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783 [TBL] [Abstract][Full Text] [Related]
7. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys. Manzione BM; Bernstein JR; Franklin RB Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422 [TBL] [Abstract][Full Text] [Related]
8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
9. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse. Hilbert J; Pramanik B; Symchowicz S; Zampaglione N Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog. Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109 [TBL] [Abstract][Full Text] [Related]
12. Comparative disposition of 2,3-epoxy-1-propanol (glycidol) in rats following oral and intravenous administration. Nomeir AA; Silveira DM; Ferrala NF; Markham PM; McComish MF; Ghanayem BI; Chadwick M J Toxicol Environ Health; 1995 Feb; 44(2):203-17. PubMed ID: 7853422 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog. Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs. Weir EC; Cashmore AR; Dreyer RN; Graham ML; Hsiao N; Moroson BA; Sawicki WL; Bertino JR Cancer Res; 1982 May; 42(5):1696-702. PubMed ID: 6461409 [TBL] [Abstract][Full Text] [Related]
16. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog. Wong BK; Woolf TF; Chang T; Whitfield LR Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548 [TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans. Barbhaiya RH; Dandekar KA; Greene DS Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195 [TBL] [Abstract][Full Text] [Related]
20. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration. Mathews JM; deCosta K; Thomas BF Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]